Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies

by Theodoros P. Vassilakopoulos, John V. Asimakopoulos, Kostas Konstantopoulos, Maria K. Angelopoulou
Published 2020-02-01

New Insights in the Mobilization of Hematopoietic Stem Cells in Lymphoma and Multiple Myeloma Patients

by Maria K. Angelopoulou, Pantelis Tsirkinidis, Georgios Boutsikas, Theodoros P. Vassilakopoulos, Panayiotis Tsirigotis
Published 2014-01-01

Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies

by Theodoros P. Vassilakopoulos, Chrysovalantou Chatzidimitriou, John V. Asimakopoulos, Maria Arapaki, Evangelos Tzoras, Maria K. Angelopoulou, Kostas Konstantopoulos
Published 2019-07-01

Significance of the detection of paroxysmal nocturnal hemoglobinuria clones in patients with multiple myeloma undergoing autologous stem cell transplantation

by Vasileios Chatziantoniou, Stavroula Alexia, Kostas Konstantopoulos, Panagiotis Repousis, Aikaterini Megalakaki, Maria Kotsopoulou, Pavlina Kylidou, Theodoros Vassilakopoulos, Maria K. Angelopoulou
Published 2015-12-01

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

by Konstantinos Anargyrou, Despina Fotiou, Theodoros P. Vassilakopoulos, Dimitrios Christoulas, Polyzois Makras, Maria Dimou, Ioannis Ntanasis-Stathopoulos, Stavroula Masouridou, Maria K. Angelopoulou, Athanasios Papatheodorou, Konstantinos Tsionos, Panayiotis Panayiotidis, Meletios A. Dimopoulos, Evangelos Terpos
Published 2019-12-01

New Insights into Monoclonal B-Cell Lymphocytosis

by Christina Kalpadakis, Gerassimos A. Pangalis, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Stavroula Kyriakaki, Penelope Korkolopoulou, Efstathios Koulieris, Maria Moschogiannis, Xanthi Yiakoumis, Pantelis Tsirkinidis, Marie-Christine Kyrtsonis, Georgia Levidou, Helen A. Papadaki, Panayiotis Panayiotidis, Maria K. Angelopoulou
Published 2014-01-01

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

by Marie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, Dimitrios Maltezas, Eftychia Nikolaou, Maria K. Angelopoulou, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, Mariana P. Siakandaris, Nora A. Viniou, Sotirios Sachanas, Christina Kalpadakis, Petros P. Sfikakis, Gerassimos A. Pangalis, Panayiotis Panayiotidis
Published 2014-01-01

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia

by Katerina Sarris, Dimitrios Maltezas, Efstathios Koulieris, Vassiliki Bartzis, Tatiana Tzenou, Sotirios Sachanas, Eftychia Nikolaou, Anna Efthymiou, Katerina Bitsani, Maria Dimou, Theodoros P. Vassilakopoulos, Marina Siakantaris, Maria K. Angelopoulou, Flora Kontopidou, Panagiotis Tsaftaridis, Nikolitsa Kafasi, Gerasimos A. Pangalis, Panayiotis P. Panayiotidis, Stephen Harding, Marie-Christine Kyrtsonis
Published 2013-01-01